TL;DR
Turn quiet afternoons into listening time
- Thousands of audiobooks, podcasts and originals
- Listen on your phone, tablet or Echo — also offline
- Cancel anytime
Researchers identified 17 plasma proteins associated with all-cause mortality in older adults, then replicated key associations in a separate cohort. Several proteins were also linked to biological-age measures across the body and specific organs, but the findings do not show that the proteins cause aging or can predict an individual’s lifespan.
Researchers have identified 17 plasma proteins associated with all-cause mortality in older adults, with several also linked to biological-age measures across multiple organ systems. The study, published in Geromedicine, analyzed blood-protein data from one group of older adults and checked key results in a second cohort, offering leads for research into aging—not a clinical test of an individual’s lifespan.
The research analyzed 4,265 proteins measured in blood samples from 1,025 participants in the LonGenity study. Participants were followed for an average of 8.05 years. Using statistical models that account for time until an event, the investigators examined how protein levels related to all-cause mortality. They also assessed links between the mortality-associated proteins, chronic disease burden, and measures of biological age for the whole body and individual organs.
Several proteins showed associations in the same direction for mortality and biological age. Higher levels of ERBB1 and ANTXR2 were associated with lower mortality risk and younger biological-age measures across multiple organ systems. Higher levels of MIC-1/GDF15, HE4 and IGFBP-2, by contrast, were associated with higher mortality risk and older biological age across multiple systems. These are statistical associations; the study does not establish that changing protein levels would change a person’s health or survival.
The investigators evaluated their results in 1,124 participants from the Baltimore Longitudinal Study of Aging, where key associations were independently replicated. The paper also reported narrower links: elevated MIC-1/GDF15 was associated with older organismal biological age, while ERBB1 was associated with younger liver biological age. The authors said the findings point to proteins for further study of the pathways connecting systemic stress, physiological balance, chronic disease and aging.
Protein Signals Across Organ Systems
People of the same chronological age can differ in health and disease burden. Measures of biological age aim to capture aspects of that variation, including how the body or particular organs may be aging. By linking some mortality-associated proteins to these measures, the study offers researchers potential clues about shared processes behind aging and health risk.
The results could help guide research into biomarkers and biological mechanisms, particularly because key findings were checked in an independent cohort. But they do not show that a protein causes aging, nor do they establish a reliable way to predict an individual’s death or diagnose future disease. Clinical use remains unproven, and the findings need further investigation before they could inform personal health decisions.
Products Worth Considering
OMRON Complete 2-in-1 Upper Arm Blood Pressure Monitor with EKG
Bowflex PR1000 Home Gym
Garmin Forerunner 165 GPS Running Smartwatch, 43 mm, Black
As an affiliate, we earn on qualifying purchases.
Two Cohorts, One Protein Analysis
The question behind the study is why people who are the same chronological age can have different levels of resilience, chronic disease and overall health. Researchers used blood-protein measurements as one way to examine that variation, comparing them with both mortality outcomes and proteome-derived biological-age measures. These estimates are research tools, not direct readings of a person’s lifespan.
The primary analysis used LonGenity participants, with follow-up averaging 8.05 years; a separate Baltimore Longitudinal Study of Aging cohort was used to evaluate key associations. The paper, titled “Exploring mortality-linked proteins: Understanding their association with biological aging, disease phenotypes, signaling pathways, and their implications for longevity,” was published open access in Geromedicine in 2026. The research involved investigators from Albert Einstein College of Medicine, Stony Brook University, the National Institute on Aging, Stanford University School of Medicine, Kannur University and collaborating institutions.
Limits of the Risk Associations
The study reports associations, not causes. It does not show whether the identified proteins contribute to aging or mortality, respond to other underlying processes, or are linked through a combination of factors. The supplied report also does not provide enough detail to assess how well the protein patterns predict outcomes for any one person.
The findings do not amount to a validated clinical blood test for estimating lifespan or future disease. The researchers identified candidate biomarkers, but further mechanistic and clinical investigation would be needed to establish their meaning, predictive performance and possible role in care. Individual risk cannot be inferred from these group-level results.
Further Validation and Mechanism Studies
The immediate next step is further research into the biological pathways associated with these proteins and whether the links hold across other groups of people. Follow-up work would also need to determine whether the proteins add useful information beyond existing measures of health and disease, and whether the observed patterns can be reproduced with methods suitable for clinical settings.
No clinical rollout or individual testing recommendation is established by this report. For now, the results serve as research leads on healthy aging and longevity, rather than a basis for predicting someone’s outcome. The source material does not specify a next study or a timeline for further results.
Key Questions
What did the study find?
It identified 17 plasma proteins associated with all-cause mortality among older adults. Several were also associated with biological-age measures, and key findings were checked in a separate cohort.
Which proteins were linked to lower mortality risk?
Higher levels of ERBB1 and ANTXR2 were associated with lower mortality risk and younger biological-age measures across multiple organ systems. The study does not establish that these proteins cause lower risk.
Which proteins were linked to higher mortality risk?
Higher levels of MIC-1/GDF15, HE4 and IGFBP-2 were associated with higher mortality risk and older biological age across multiple systems.
Can a blood test based on these findings predict how long I will live?
No clinical test for predicting an individual’s lifespan was established. The study found statistical associations in two research cohorts, and individual prediction and clinical use remain unproven.
Do the proteins cause biological aging?
The study does not show that the proteins cause aging or mortality. It identifies relationships that researchers can investigate in further mechanistic and clinical studies.
Source: news-medical.net
